Funding Opportunities

The University of Alberta, one of Canada's most research-intensive universities, is proud of the vitality and quality of research and scholarship activities of its faculty and staff. The Research Services Office supports researchers by identifying potential research funding sources and by helping researchers to process and manage applications and awards.

Researchers are encouraged to contact their Faculty-assigned Research Facilitator for more information about funding opportunities.


Health Sciences

Natural Sciences and Engineering

Social Sciences and the Humanities


Health Sciences


Alberta Cancer Foundation

Cancer Detection Challenge

Description: This Challenge seeks to identify and support the development of cancer detection and diagnosis technologies that will enhance outcomes for patients with cancer while simultaneously driving the growth of a local Alberta diagnostics company.


Deadline: June 21, 2017 (Application)



Alberta Health Services

2017 Master's Studentship Award

Description: Strategic Clinical Network™ (SCN) Scientific Offices were created to lead Alberta Health Services (AHS) in the promotion, adoption and diffusion of innovation as well as the creation and use of evidence to drive decision-making. The Emergency SCN and Seniors Health SCN Scientific Offices have identified the provision of scholarship funds to a Master’s student as an opportunity to build research capacity and advance knowledge. The goal of this activity is to support a highly qualified Master’s level student conducting research related to older persons’ emergency medicine care or experiences.

The 2017 Joint Emergency SCN & Seniors Health SCN Master’s Award will fund one (1) student in the second year of their graduate program. The value of the award is $14,000 for the twelve (12) month period from September 1, 2017 to August 31, 2018. The award is non-renewable. Any proposed clinical, health services, or population health research question that has relevance to seniors’ emergency medicine care or experiences will be considered. Basic science (Pillar 1) research will not be considered.

More Details

Application

Deadline: July 30, 2017



Alzheimer Society Canada

ASRP Postdoctoral Fellowship in Women’s Brain Health and Aging

Description: The purpose of this opportunity is to provide training to an exceptional Postdoctoral Fellow who will work under the mentorship and supervision of Dr. Gillian Einstein, the Wilfred and Joyce Posluns Chair in Women’s Brain Health and Aging. The focus of this postdoctoral fellowship position is to carry out a study of brain changes over time in middle aged women who have had their ovaries removed. Primary research methods are neuropsychological testing, brain imaging and hormone measures. State of the art imaging facilities exist at Baycrest Hospital as well as at the Department of Psychology at the University of Toronto. This position will offer local and international opportunities for collaborating and conferencing. This study has multiple sites and opportunities to spend time at the different sites exist.

Website

Deadline: June 16, 2017 (Application)



Burroughs Wellcome Fund

Investigators in the Pathogenesis of Infectious Disease

Description: The Investigators in the Pathogenesis of Infectious Disease (PATH) award provides $500,000 over five years to support accomplished investigators at the assistant professor level to study pathogenesis, with a focus on the interplay between human and microbial biology, shedding light on how human and microbial systems are affected by their encounters.

The Investigators in the Pathogenesis of Infectious Disease program provides opportunities for assistant professors to bring multidisciplinary approaches to the study of human infectious diseases. The goal of the program is to provide opportunities for accomplished investigators still early in their careers to study what happens at the points where the systems of humans and potentially infectious agents connect. The program supports research that sheds light on the fundamentals that affect the outcomes of these encounters: how colonization, infection, commensalism, and other relationships play out at levels ranging from molecular interactions to systemic ones.

Website

Deadline: July 14, 2017 (Pre-proposals); November 15, 2017 (Invited Proposal)


Campus Alberta Neuroscience (CAN)

Conference Support Program

Description: CAN offers support for Alberta-based conferences related to neuroscience and mental health research, education, and translation, through the Conference Support Program.

Website

Contact: Campus Alberta Neuroscience at (403) 220-2422 or albertaneuro@ucalgary.ca

Deadline: Ongoing


Canadian Cancer Society Research Institute (CCSRI)

Quality of Life Research Grants

Description: Intended to explore psychosocial, survivorship, symptom control, supportive care and end-of-life issues, research gaps, needs and opportunities, or models for survivorship care. The grants are meant to accelerate and focus the knowledge gained from scientific findings, in the short or long term, into outcomes that will result in the reduced burden or enhanced quality of life for cancer patients in Canada and elsewhere.

Website

Deadline: May 15, 2017 (LOI); November 1, 2017 (Application)


Canadian Institutes of Health Research

Fellowship : Banting Postdoctoral Fellowships Program (2017-2018)

Description: The Banting Postdoctoral Fellowships Program is distinguished from existing postdoctoral fellowships programs by its emphasis on the synergy between an applicant’s individual merit and potential to launch a successful research-intensive career and the host institution’s commitment to the research program and environment with which the applicant is to be affiliated. As such, an applicant’s application to the Banting Postdoctoral Fellowships Program must be completed in full collaboration with the proposed host institution.

Website

Deadline: Sept 20, 2017


Team Grant - Human Immunology Initiative: Standardization Core

Description: The aim of the Standardization Core is to create common measurements, indicators and outcomes that can be used for comparative purposes across populations and studies, including identifying and addressing ethical issues. The successful applicant to the Standardization Core funding opportunity will constitute a best practices platform, and will be responsible for the development and validation of standard operating procedures (SOPs) in human immunology, applied to the field of autoimmune disease research, by aligning with work conducted at the international level.

Website

Deadline: June 6, 2017 (LOI); March 6, 2018 (Application)


Catalyst Grant : HIV/AIDS Community-Based Research (2017)

Description: The CIHR HIV/AIDS Community-Based Research (CBR) Program is one of five research funding areas of the CIHR HIV/AIDS Research Initiative. The CIHR HIV/AIDS Research Initiative is responsible for the research components of the two major Government of Canada initiatives in HIV/AIDS, namely the Federal Initiative to Address HIV/AIDS in Canada and the Canadian HIV Vaccine Initiative. The CIHR HIV/AIDS CBR Program supports the partnered work of Community Leaders and Researchers in knowledge development and capacity-building initiatives of relevance to communities engaged in the fight against HIV/AIDS. All opportunities offered through the CBR Program are available in two distinct funding streams: Indigenous and General. The aim of the Catalyst Grant component of the CBR program is to provide seed money to support HIV/AIDS CBR research activities which represent a first step towards the pursuit of more comprehensive funding opportunities (e.g., operating grants). For examples, applicants can visit CIHR's Funding Decisions web site to search for projects previously funded under a CIHR HIV/AIDS CBR Catalyst Grant.

Website

Deadline: October 3, 2017 (Application)


Catalyst Grant : Population Health Intervention Research on Legalization of Cannabis

Description: Canada is taking the unprecedented step of legalizing and regulating the use of cannabis for non-medical purposes. While other jurisdictions are experimenting with different forms of legalization, there is little precedent for such activities at the national level. There are also still many unknowns related to the health effects of cannabis and to the behavioural, social, and economic implications of legalization and regulation. Despite this lack of knowledge, cannabis is currently being used for many medical and non-medical purposes. Consequently, a number of reports recently highlighted the need for enhanced research evidence in this area to inform policy decisions, programs, practices, and prevention efforts. The Catalyst Grant: Population Health Intervention Research on the Legalization and Regulation of Non-Medical Cannabis in Canada is expected to:

  • Support the prompt initiation of intervention research that will assess how the legalization and regulation of non-medical cannabis in Canada could directly or indirectly impact population health and health equity;
  • Generate data and evidence to monitor and evaluate the potential benefits, harms, and unintended consequences of legalizing and regulating non-medical cannabis to population health and health equity; and
  • Facilitate consideration and application of new evidence from population health intervention research to inform ongoing and future development of policies, practices, and programs involving cannabis.


Website

Deadline: August 22, 2017 (Application)


Operating Grant : Collaborative Health Research Program (2017-2018)

Description: The CHRP Initiative funding supports innovative, interdisciplinary, collaborative research projects, requiring participation from the natural sciences or engineering community together with the health sciences community. The CHRP Initiative funding requires the translation of the research results to knowledge/technology users (KTUs) and related stakeholders outside the academic or training environment. As such, the proposed research projects must have a strong focus on knowledge translation (KT) and lead to health and economic benefits for Canadians, more effective health services and products, and/or a strengthened health care system. KTU organizations should be meaningfully engaged throughout the research process, as appropriate, to inform research planning and design. For more information on KT at CIHR, please see About KT. Applicants are also encouraged to refer to CIHR’s Guide to Knowledge Translation Planning at CIHR: Integrated and End-of-Grant Approaches and "Knowledge to Action: A Knowledge Translation Casebook" for additional guidance.

The CHRP Initiative projects must include training opportunities for trainees in collaborative and interdisciplinary research of relevance to health, preparing them for employment opportunities in the private, public or not for profit sectors. Given that interactions between personnel from academic institutions and other sectors contribute to knowledge sharing and the development of trainees, NSERC and CIHR encourage secondments, cross-appointments, co-supervision of students, internships, reciprocal laboratory visits and joint workshops.

Website

Deadline: June 6, 2017 (Letters of Intent); October 17, 2017 (Application)


Operating Grant : HIV/AIDS Community-Based Research (2017-2018)

Description: The CIHR HIV/AIDS Community-Based Research (CBR) Program is one of five research funding areas of the CIHR HIV/AIDS Research Initiative. The CIHR HIV/AIDS Research Initiative is responsible for the research components of the two major Government of Canada initiatives in HIV/AIDS, namely the Federal Initiative to Address HIV/AIDS in Canada and the Canadian HIV Vaccine Initiative. The CIHR HIV/AIDS CBR Program supports the partnered work of Community Leaders and Researchers in knowledge development and capacity-building initiatives of relevance to communities engaged in the fight against HIV/AIDS. All opportunities offered through the CBR Program are available in two distinct funding streams: Indigenous and General. The aim of the Operating Grant component of the CBR program is to contribute to the creation, dissemination and use of health-related knowledge, and to help develop research capacity, by supporting original, high quality projects proposed and conducted in partnership between the community and academia.

Website

Deadline: October 3, 2017 (Application)


Other : Best Brains Exchange Travel Award (2017-2018)

Description: The Best Brains Exchange program is designed to provide high-quality, timely, and accessible evidence that responds to Ministry and Health Portfolio-identified health system priorities to help inform policy development, planning and program implementation. The program was developed to amplify CIHR’s capacity to engage with provincial and territorial ministries of health and the Health Portfolio, and to generate applied and relevant research that is responsive to their priorities.

Best Brains Exchanges are one-day, in-camera meetings for decision makers and researchers with expertise on a particular topic deemed as a high priority by the Ministry or Health Portfolio. More specifically, Best Brains Exchanges are a forum to highlight existing and relevant research evidence on the topic; identify gaps in evidence; bring together both decision maker and researcher expertise on a policy issue; and candidly discuss the applicability of the research for the department/agency. A Best Brains Exchange is an informal forum for interaction, exchange and mutual learning between researchers and decision makers in order to support and facilitate the sharing and use of information on a high priority topic.

Website

Deadline: Various. Prior to preparing an application, applicants must have been pre-identified and invited by CIHR to participate in a Best Brains Exchange session.


Other : Healthy Behaviour Data Challenge
Other : Healthy Behaviour Data Challenge

Description: The Healthy Behaviour Data Challenge is an international partnership between Canada (CIHR and the Public Health Agency of Canada) and United States partners (the U.S. Centers for Disease Control and Prevention and the U.S. Department of Health and Human Services). The challenge is led and managed by the MaRS Discovery District. The competition is focused on the identification and evaluation of new data and data sources for use in public health surveillance. In particular, the challenge will incentivize the identification and aggregation of data from non-traditional data sources including wearables, social media and mobile applications, to measure indicators of physical activity, sedentary behaviour and sleep. The use of this incentive prize design will offer an opportunity to expand research opportunities, advance new knowledge, and address key data gaps and needs in population health surveillance in Canada.

Website

Deadline: August 4, 2017 (Phase 1); January 15, 2018 (Phase 2)


Canadian Institutes of Health Research - Institute of Health Services and Policy Research (CIHR - IHSPR)


Canadian Lyme Disease Foundation (CanLyme)

Venture Grants

Description: CanLyme's Venture Grants program supports research on Lyme and associated tick-borne diseases. Researchers at Canadian institutions are invited to apply.

Website

Contact: Reuben Kaufman at rkaufman@ualberta.ca

Deadline: Ongoing


CQDM : Enabling Drug Discovery

Quantum Leap

Description: This program funds SMEs to further develop platforms while positioning them advantageously for commercialization. CQDM has reserved a $1,000,000 envelop to pilot this new strategic initiative. The number of funded projects as well as the budget available for any individual one will depend on the proposed research project.

Website

Deadline: Ongoing


Department of Defense -- Dept. of the Army

ALSRP Therapeutic Idea Award

Description: The Therapeutic Idea Award is designed to promote new ideas aimed at drug or treatment discovery that are still in the early stages of development. Development, modification, and/or validation of preclinical model systems or the application of high-throughput screens to define or assess lead compounds for ALS treatment are of interest. While the inclusion of preliminary data is not prohibited, the strength of the application should not rely on preliminary data, but on the innovative idea and the potential impact it will provide. The Therapeutic Idea Award encourages applications that include meaningful and productive collaborations between investigators. As appropriate, applicants are encouraged to collaborate with industry partners and/or established ALS researchers.

Website

Deadline: 5pm ET June 9, 2017 (Pre-Application); August 31, 2017 (Application)


Breast Cancer Innovator Award

Description: The Innovator Award supports visionary individuals who have demonstrated exceptional creativity, innovative work, and paradigm-shifting leadership in any field including, but not limited to, breast cancer. The Innovator Award will provide these individuals with the funding and freedom to pursue their most novel, visionary, high-risk ideas that could accelerate progress to ending breast cancer. Because the intent of the Innovator Award mechanism is to recognize these remarkably creative and innovative visionary individuals, rather than projects, the central feature of the award is the innovative contribution that the Principal Investigator (PI) can make toward ending breast cancer. The PI’s research team must include two or more breast cancer consumer advocates. As lay representatives, the consumer advocates must be individuals who have been diagnosed with breast cancer and are actively involved in a breast cancer advocacy organization. Their role should be focused on providing objective input on the research and its potential impact for individuals with, or at risk for, breast cancer.

Website

Deadline: 5pm ET June 9, 2017 (Pre-Application); August 31, 2017 (Application)


Breast Cancer Distinguished Investigator Award

Description: The BCRP Distinguished Investigator Award enables established visionary leaders from any field to pursue innovative ideas that could accelerate progress toward ending breast cancer. These individuals should be exceptionally talented researchers who have shown that they are leaders in their field(s) through extraordinary creativity, vision, and productivity. The central feature of the Distinguished Investigator Award is that the PI must propose research that is a fundamental shift from his/her track record of research and addresses one or more BCRP overarching challenge(s). Applications that are a continuation or incremental change from the PI’s published line of research do not meet the intent of this award. The PI’s research team must also include two or more breast cancer consumer advocates. As lay representatives, the consumer advocates must be individuals who have been diagnosed with breast cancer and are actively involved in a breast cancer advocacy organization. Their role should be independent of their employment, and they cannot be employees of any of the organizations participating in the application. The consumer advocates should have a high level of knowledge of current breast cancer issues and the necessary background or training in breast cancer research to contribute to the project. Their role should be focused on providing objective input on the research and its potential impact for individuals with, or at risk for, breast cancer.

Website

Deadline: 5pm ET June 9, 2017 (Pre-Application); August 31, 2017 (Application)


ALSRP Therapeutic Development Award

Description: The Therapeutic Development Award supports a wide range of development activities ranging from validation of therapeutic leads to U.S. Food and Drug Administration (FDA) Investigational New Drug (IND) application submission. The proposed studies are expected to be empirical in nature and product-driven. Applications supported by this award must begin with lead compounds in hand.

Website

Deadline: 5pm ET June 9, 2017 (Pre-Application); August 31, 2017 (Application)


Breast Cancer Breakthrough Fellowship Levels 3 and 4

Description: The intent of the Breakthrough Award is to support promising research that has high potential to lead to or make breakthroughs in breast cancer. Research supported by the Breakthrough Award will have the potential for a major impact and accelerate progress toward ending breast cancer. The impact may be near-term or long-term, but must be significant and move beyond an incremental advancement. Applications must articulate the pathway to making a clinical impact for individuals with, or at risk for, breast cancer, even if clinical impact is not an immediate outcome. The research team must include two or more breast cancer consumer advocates, who will be integral throughout the planning and implementation of the research project. Consumer advocates should be involved in the development of the research question, project design, oversight, recruitment, and evaluation, as well as other significant aspects of the proposed project. Interactions with other team members should be well integrated and ongoing, not limited to attending seminars and semi-annual meetings. As lay representatives, the consumer advocates must be individuals who have been diagnosed with breast cancer, and they should be active in a breast cancer advocacy organization. Their role in the project should be independent of their employment, and they cannot be employees of any of the organizations participating in the application. Their role should be focused on providing objective input on the research and its potential impact for individuals with, or at risk for, breast cancer. The consumer advocates should have a high level of knowledge of current breast cancer issues and the necessary background or training in breast cancer research to contribute to the project.

Website

Deadline: 5pm ET June 9, 2017 (Pre-Application); August 31, 2017 (Application)


Ovarian Cancer Investigator-Initiated Research Award

Description: The OCRP Investigator-Initiated Research Award is intended to support high-impact research that has the potential to make an important contribution to ovarian cancer or patient/survivor care. Research projects may focus on any phase of research, from basic laboratory research through translational research, excluding clinical trials. The application must demonstrate logical reasoning and a sound scientific rationale established through a critical review and analysis of the literature for the application to be competitive. Applications must include preliminary data that are relevant to ovarian cancer and support the proposed research project.

Website

Deadline: 5pm June 21, 2017 (Pre-Application); September 6, 2017 (Application)


Ovarian Cancer Clinical Development Award

Description: The OCRP Clinical Development Award is intended to provide support for the translation of promising preclinical findings into products for clinical applications, including prevention, detection, diagnosis, treatment, or quality of life. The goal of this award mechanism is to accelerate the clinical introduction of medical products and technologies that target ovarian cancer biology. Near-term clinical impact is expected. Proof of concept demonstrating the potential utility of the proposed product or a prototype/ preliminary version of the proposed product should already be established; thus, preclinical studies in animals are not allowed. Small-scale clinical trials (Phase 0, Phase 1, Pilot), studies enriching a clinical trial, and projects related to or associated with ongoing or completed clinical trials are allowed. Relevant data, either published or unpublished, that support the study rationale are required.

Website

Deadline: 5pm ET June 21, 2017 (Pre-Application); September 6, 2017 (Application)


Ovarian Cancer Academy – Early-Career Investigator Award

Description: The OCRP Ovarian Cancer Academy, which was initially created in FY09, is a unique, interactive virtual academy providing intensive mentoring, national networking, and a peer group for junior faculty. The overarching goal of the Ovarian Cancer Academy is to develop successful, highly productive ovarian cancer researchers in a collaborative research and career development environment. The Ovarian Cancer Academy is a virtual career development and research training platform that consists of Early-Career Investigators and their Designated Mentors from different institutions, and an Academy Dean and Assistant Dean. The Academy Leadership serves as a resource for the Early-Career Investigators and Mentors, assessing the progress of the Early-Career Investigators, and facilitating communication and collaboration among all of the Early-Career Investigators and Mentors, as well as with national research and advocacy communities.

Website

Deadline: 5pm ET June 21, 2017 (Pre-Application); September 6, 2017 (Application)


Bone Marrow Failure Idea Development Award

Description: The BMFRP Idea Development Award is intended to support innovative ideas and high-impact approaches based on scientifically sound evidence to move toward the BMFRP vision of understanding and curing BMF diseases. This award mechanism is designed to support new ideas. Proposed research studies should have a high probability of revealing new avenues of investigation. The research project should include a well-formulated, testable hypothesis based on strong scientific rationale and a well-developed and articulated research approach. Personnel on the proposed team should have a strong background in BMF research. The anticipated direct costs budgeted for the entire period of performance for an FY17 BMFRP Idea Development Award will not exceed $315,000.

Website

Deadline: 5pm ET July 13, 2017 (Pre-Application); October 5, 2017 (Application)


Multiple Sclerosis Research Program, Investigator-Initiated Research Award

Description: The Investigator-Initiated Research Award supports highly rigorous, high-impact research projects that have the potential to make an important contribution to MS research and/or patient care. Research projects may focus on any phase of research, excluding clinical trials. The rationale for a research idea may be derived from laboratory discovery, clinical trial results, population-based studies, a clinician’s firsthand knowledge of patients, or anecdotal data. Applications must include preliminary and/or published data that are relevant to MS and the proposed research project.

Website

Deadline: 5pm ET June 26, 2017 (Pre-Application); October 5, 2017 (Application)


DoD Vision Research Program, Technology/Therapeutic Development Award

Description: The FY17 VRP TTDA is a mission-driven award mechanism intended to provide support for the translation of promising preclinical findings into products for clinical applications, including detection, diagnosis, treatment, or quality of life, in at least one of the FY17 VRP TTDA Capability Gaps. Products in development should be responsive to the healthcare needs of military Service members, Veterans, and other individuals living with visual dysfunction. NOTE: In keeping with the intent of this award mechanism, at the end of this award's period of performance, research results should be sufficient to support an Investigational Device Exemption (IDE), Investigational New Drug (IND), or continue to clinical trials (where applicable).

Website

Deadline: 5pm ET July 12, 2017 (Pre-Application); October 25, 2017 (Application)


DoD Lung Cancer Translational Research Partnership Award

Description: The FY17 LCRP Translational Research Partnership Award mechanism supports partnerships between clinicians and research scientists that will accelerate the movement of promising ideas in lung cancer into clinical applications. This award supports the development of translational research collaborations between two independent, faculty level (or equivalent) investigators to address a central problem or question in lung cancer in a manner that would be less readily achievable through separate efforts. One partner in the collaboration must be a research scientist and the other must be a clinician. In addition, one partner in the collaboration is strongly encouraged to be an active duty Service member or Federal employee from a military treatment facility, Department of Defense (DoD) laboratory, or a Department of Veterans Affairs (VA) medical center or research laboratory. The ultimate goal of translational research is to move a concept or observation forward into clinical application. However, members of the partnership should not view translational research as a one-way continuum from bench to bedside. The research plan must involve a reciprocal flow of ideas and information between basic and clinical science.

Website

Deadline: 5pm ET June 28, 2017 (Pre-Application); September 27, 2017 (Application)


DoD Vision Research Program, Clinical Trial Award

Description: The FY17 VRP CTA supports research with the potential to have a major impact on the treatment or management of visual injury and/or dysfunction. Funding from this award mechanism must support a clinical trial and should not be used for preclinical research studies. Principal Investigators (PIs) seeking funding for preclinical research, including non-clinical trial research with human subjects, should apply to the FY17 VRP Technology/ Therapeutic Development Award mechanism (W81XWH-17-VRP-TTDA). Applications proposing research outside of the capability gaps listed above should not be submitted in response to this Program Announcement/Funding Opportunity.

Website

Deadline: 5pm ET July 12, 2017 (Pre-Application); October 25, 2017 (Application)


DoD Lung Cancer Idea Development Award

Description: The FY17 LCRP Idea Development Award mechanism promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation. This award supports conceptually innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress toward eradicating deaths from lung cancer. Applications should include a well-formulated, testable hypothesis based on strong scientific rationale. Submissions from and partnerships with investigators at military treatment facilities, military labs, and Department of Veterans Affairs (VA) medical centers and research laboratories are strongly encouraged.

Website

Deadline: 5pm ET June 28, 2017 (Pre-Application); September 27, 2017 (Application)


DoD Multiple Sclerosis Research Program, Exploration-Hypothesis Development Award

Description: The Exploration – Hypothesis Development Award supports the initial exploration of innovative, high-risk, high-gain, and potentially groundbreaking concepts in the MS research field. The studies supported by this award mechanism are expected to lay the groundwork for future avenues of scientific investigation. The proposed research project should include a well-formulated, testable hypothesis based on strong scientific rationale and study design. The presentation of preliminary and/or published data is not required. The proposed research project should be innovative, feasible, and supported by strong rationale. Innovative research may examine a novel paradigm, challenge current paradigms, look at existing problems from novel perspectives, or exhibit other highly creative qualities. Research that is an incremental advance beyond ongoing research and published data is not considered innovative and is not consistent with the intent of this award mechanism. It is the responsibility of the Principal Investigator (PI) to clearly and explicitly articulate how the proposed research project is innovative in the field of MS research.

Website

Deadline: 5pm ET June 26, 2017 (Pre-Application); October 5, 2017 (Application)


DoD Lung Cancer, Concept Award

Description: The FY17 LCRP Concept Award supports the exploration of a highly innovative new concept or untested theory that addresses an important problem relevant to lung cancer. The Concept Award is not intended to support an incremental progression of an already established research project but, instead, allows Principal Investigators (PIs) the opportunity to pursue serendipitous observations. This award mechanism supports high-risk studies that have the potential to reveal entirely new avenues for investigation. Applications must describe how the new idea will enhance the existing knowledge of lung cancer or develop an innovative and novel course of investigation. Submissions from and partnerships with investigators at military treatment facilities, military labs, and Department of Veterans Affairs (VA) medical centers and research laboratories are strongly encouraged.

Website

Deadline: 5pm ET 27 July, 2017 (Pre-Application); August 10, 2017 (Application)


DoD Gulf War Illness, Qualitative Research Award

Description: The GWIRP Qualitative Research Award mechanism is being offered for the first time in FY17. Qualitative research is a form of social inquiry that seeks to understand the human experience by exploring how people interpret and make sense of their experiences and the world in which they live. The intent of the FY17 GWIRP Qualitative Research Award is to support qualitative research studies that seek to understand the experiences, perceptions, barriers, and beliefs of Veterans suffering from GWI and those responsible for their care. Observations that drive a research idea may be derived from basic discovery, population-based studies, a clinician’s firsthand knowledge of patients, or anecdotal data.

Website

Deadline: 5pm ET June 30, 2017 (Pre-Application); September 21, 2017 (Application)


DoD Gulf War Illness, Biorepository Resource Network Award

Description: The Biorepository Resource Network Award (BRNA) is being offered for the first time in FY17. The FY17 GWIRP BRNA is intended to provide infrastructure support for the development of a GWI biorepository comprised of a network of institutions that will collect, process, annotate, store, and distribute high-quality biospecimens and data from Veterans of the 1990-1991 Persian Gulf War. In addition to biospecimens, this biorepository is intended to house biological data from previous studies (e.g., imaging or -omics data without specimens attached). The development of the biorepository resource network will enable the GWI research community to conduct research that will address the mission of the GWIRP.

Website

Deadline: 5pm ET June 30, 2017 (Pre-Application); September 21, 2017


DoD Gulf War Illness, Clinical Consortium Award

Description: The GWIRP Clinical Consortium Award mechanism is being offered for the first time in FY17. The FY17 GWIRP Clinical Consortium Award is intended to support a major goal-/product-driven Consortium of exceptional institutions and investigators that will accelerate the clinical translation of basic GWI research into clinical therapies and ultimately decrease the impact of the illness. The objectives of the Consortium shall be to conceive, design, develop, and conduct collaborative Phase I and/or II clinical trials of promising therapeutic agents for the management or treatment of GWI.

Website

Deadline: 5pm ET June 30, 2017 (Pre-Application); September 21, 2017 (Application)


DoD Gulf War Illness, Investigator-Initiated Focused Research Award

Description: The IIFRA supports research to promote new ideas or continued development of applied research in GWI that is aimed at diagnosis or therapeutic advancement. Applications must articulate the pathway to making a clinical impact for Veterans with GWI even if a clinical impact is not an immediate outcome. All applications must focus on Veterans of the 1990-1991 Gulf War affected by GWI. It is the responsibility of the Principal Investigator (PI) to clearly and explicitly articulate the project’s potential impact on GWI.

Website

Deadline: 5pm ET June 30, 2017 (Pre-Application); September 21, 2017


DoD Tick-Borne Disease Idea Award

Description: The FY17 TBDRP Idea Award intends to support conceptually innovative, high-risk/potentially high-reward research in the early stages of development that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals affected by Lyme disease and/or other tick-borne illnesses. This award mechanism promotes new ideas that represent innovative approaches to Lyme disease and other tick-borne diseases research and have the potential to make an important contribution toward the TBDRP mission. Applications should include a well-formulated, testable hypothesis based on strong scientific rationale that is established through inferential reasoning and/or critical review and analysis of the literature.

Website

Deadline: 5pm ET July 5, 2017 (Pre-Application); October 11, 2017 (Application)


DoD Tick-Borne Disease Investigator-Initiated Research Award

Description: The FY17 TBDRP Investigator-Initiated Research Award (IIRA) intends to support highly rigorous, high-impact studies that have the potential to make important contributions to Lyme disease and other tick-borne diseases research, patient care, and/or quality of life. This award mechanism promotes a wide range of research from basic through translational, including preclinical studies in animal models or human subjects, as well as correlative studies associated with an existing clinical trial to establish proof-of-principle for further development in future studies. Applications should include a well-formulated, testable hypothesis based on strong scientific rationale that is established through logical reasoning, preliminary data, and critical review and analysis of the literature.

Website

Deadline: 5pm ET July 5, 2017 (Pre-Application); October 11, 2017 (Application)


DoD Tuberous Sclerosis Complex Research Program, Idea Development Award

Description: The Idea Development Award promotes ideas that have the potential to yield high-impact findings and new avenues of investigation. This award mechanism supports conceptually innovative research that could ultimately lead to critical discoveries in TSC research and/or improvements in patient care. Research projects should include a well-formulated, testable hypothesis based on strong preliminary data and scientific rationale.

Website

Deadline: 5pm July 11, 2017 (Pre-Application); July 27, 2017 (Application)


DoD Tuberous Sclerosis Complex Research Program, Clinical Translational Research Award

Description: The Clinical Translational Research Award supports forward and/or reverse clinical/translational studies that have a reciprocal flow of ideas and information between basic and clinical science and have the potential to improve the diagnosis, prognosis or treatment of TSC. Projects supported by this award mechanism may include studies moving from preclinical to clinical research (including a pilot clinical trial) and/or the reverse, analyzing human anatomical substances and/or data associated with clinical trials (such as correlative studies) to develop models that recapitulate relevant clinical outcomes for use in translational research. Developmental pathways for translational research that may be useful for designing translational research studies for support under this mechanism can be found in the report of the National Cancer Institute Translational Research Working group (http://clincancerres.aacrjournals.org/content/14/18/5664.full). These pathways are comprehensive and span the entire translational research continuum from bench to bedside to bench.

Website

Deadline: 5pm ET July 11, 2017 (Pre-Application); July 27, 2017 (Application)


FY17 DoD Tuberous Sclerosis Complex Research Program, Exploration- Hypothesis Development Award

Description: The Exploration – Hypothesis Development Award supports the initial exploration of innovative, high-risk, high-gain, and potentially groundbreaking concepts in the TSC research field. The studies supported by this award mechanism are expected to generate preliminary data for future avenues of scientific investigation. The proposed research project should include a well-formulated, testable hypothesis based on strong scientific rationale and study design.

Website

Deadline: 5pm ET July 11, 2017 (Pre-Application); July 27, 2017 (Application)


DoD Prostate Cancer Clinical Consortium Award

Description: The PCRP Clinical Consortium Award mechanism was first offered in FY05, and again in FY06, FY08, and FY13. In FY16, the Clinical Consortium Research Site Award was offered. A total of 75 Clinical Consortium Award applications have been received, and 42 have been recommended for funding.The anticipated direct costs budgeted for the entire period of performance for an FY17 PCRP Clinical Consortium Award will not exceed $3,600,000 for the Coordinating Center and will not exceed $600,000 for each Clinical Research Site. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.The Clinical Consortium Award mechanism provides the support to develop and enhance collaborations and resources necessary for a network of organizations to rapidly execute Phase II or Phase II-linked Phase I (Phase I/II) prostate cancer clinical trials. These trials will include investigations of high-impact, novel therapeutic agents or approaches for the management or treatment of prostate cancer, especially as pertaining to the FY17 PCRP Overarching Challenges. Support from this award is directed toward consortium infrastructure needs rather than direct support of the research itself. In accordance with PCRP goals, the conduct of Phase I/II trials that incorporate investigations of biomarkers for risk assessment, early detection, prediction of aggressiveness, and/or progression of prostate cancer is particularly encouraged.The principal goal of the Clinical Consortium Award is to combine the efforts of leading investigators to bring to market high-impact, novel therapeutic interventions that will ultimately and significantly decrease the impact of the disease. To facilitate global investigations, Principal Investigators (PIs) from both U.S. and international institutions are encouraged to apply.

Website

Deadline: 5pm ET August 24, 2017 (Pre-Application); September 7, 2017 (application)


DoD Prostate Cancer Early Investigator Research Award

Description: The PCRP Early Investigator Research Award mechanism was first offered in FY16. Since then, 97 Early Investigator Research Award applications have been received, and 21 have been recommended for funding. In FY16, the Early Investigator Research Award supported both predoctoral and postdoctoral investigators. In FY17, this award will fund only postdoctoral investigators. The anticipated direct costs budgeted for the entire period of performance for an FY17 PCRP EIRA award will not exceed $200,000. Refer to Section II.D.5, Funding Restrictions, for detailed funding information. The Early Investigator Research Award supports prostate cancer-focused research opportunities for individuals in the early stages of their careers, under the guidance of a designated Mentor. This opportunity allows for young investigators to develop a research project, investigate a problem or question in prostate cancer research, and further their intellectual development as a prostate cancer researcher of the future. The postdoctoral investigator is considered the Principal Investigator (PI) of the application and must exhibit strong potential for, and commitment to, pursuing a career as an investigator at the forefront of prostate cancer research; however, the PI is not required to have previous prostate cancer research experience. Applications must include at least one Mentor, appropriate to the proposed research project, who has experience in prostate cancer research and mentoring as demonstrated by a record of active funding, recent publications, and successful mentorship.

Website

Deadline: 5pm ET July 27, 2017 (Pre-Application); August 10, 2017 (Application)


DoD Prostate Cancer Health Disparity Research Award

Description: The PCRP Health Disparity Research Award mechanism was first offered in FY01. Since then, 499 Health Disparity Award applications have been received, and 87 have been recommended for funding. The anticipated direct costs budgeted for the entire period of performance for an FY17 PCRP HDRA award will not exceed $450,000. Refer to Section II.D.5, Funding Restrictions, for detailed funding information. The Health Disparity Research Award supports new ideas based on innovative concepts or methodologies for health disparity research with the potential to make an important contribution toward eliminating death from prostate cancer and enhancing the well-being of men impacted by the disease. Studies proposed for this award mechanism are expected to improve the understanding of and/or address factors that contribute to differences in the disease experience across populations, ultimately contributing to eliminating disparities in prostate cancer incidence, morbidity, mortality, and survivorship. Applicants for this award must explicitly state how the proposed research is related to an area of prostate cancer health disparity.

Website

Deadline: 5pm ET July 7, 2017 (Pre-Application); September 28, 2017 (Application)


DoD Prostate Cancer Physician Research Award

Description: The PCRP Physician Research Award mechanism was first offered in FY03. Since then, 208 Physician Research Award applications have been received, and 80 have been recommended for funding. The anticipated direct costs budgeted for the entire period of performance for an FY17 PCRP Physician Research Award will not exceed $520,000. Refer to Section II.D.5, Funding Restrictions, for detailed funding information. The Physician Research Award supports a mentored research experience to prepare physicians with clinical duties and/or responsibilities for productive careers in prostate cancer research. The mentored physician is considered the Principal Investigator (PI) of the application. This award emphasizes equally the quality of the proposed research project and the career development of the PI, which should prepare physicians for careers in basic, population science, translational, or clinical prostate cancer research. All applications for the Physician Research Award are to be written by the PI, with appropriate direction from the Mentor(s).

Website

Deadline: 5pm ET July 27, 2017 (Pre-Application); August 10, 2017 (Application)


DoD Prostate Cancer Idea Development Award

Description: The PCRP Idea Development Award mechanism was first offered in FY97. Since then, 9,389 Idea Development Award applications have been received, and 1,199 have been recommended for funding. The anticipated direct costs budgeted for the entire period of performance for an FY17 PCRP Ideal Development Award will not exceed $375,000 for an award under the New Investigator category, $600,000 for an award under the Established Investigator category, or $1M for an award under the Established Investigator – Partnering PI Option. Refer to Section II.D.5, Funding Restrictions, for detailed funding information. The Idea Development Award supports new ideas that represent innovative approaches to prostate cancer research and have the potential to make an important contribution to the PCRP mission. Although groundbreaking research often involves a degree of risk, applications should be based on a sound scientific rationale that is established through logical reasoning and/or critical review and analysis of the literature. Due to this award’s emphasis on innovation, the presentation of preliminary data relevant to prostate cancer and the proposed project is encouraged, but not required.

Website

Deadline: 5pm ET July 14, 2017 (Pre-Application); October 26, 2017 (Application)


DoD Prostate Cancer Pathology Resource Network Award

Description: The Prostate Cancer Pathology Resource Network (PCPRN or Network) Award mechanism was previously offered in FY09 and FY13. In FY14, the Prostate Cancer Biospecimen Resource Site Award was offered to add additional sites to the Network. Since then, 6 PCPRN Award applications were received for the Coordinating Center plus Pathology Resource Site, with 2 being funded, and 19 were received for Pathology/Biospecimen Resource Sites, with 5 being funded. The anticipated direct costs budgeted for the entire period of performance for an FY17 PCRP PCPRN Award will not exceed $3.6M.

Website

Deadline: 5pm ET August 24, 2017 (Pre-Application); September 7, 2017 (Application)


DoD Prostate Cancer Impact Award

Description: The PCRP Impact Award mechanism was first offered in FY10. Since then, 213 Impact Award applications have been received, and 30 have been recommended for funding. The anticipated direct costs budgeted for the entire period of performance for an FY17 PCRP IA award will not exceed $750,000 for a Single PI and will not exceed $2M for a Partnering PI Option. Refer to Section II.D.5, Funding Restrictions, for detailed funding information. The Impact Award encourages applications that support the full spectrum of research projects or ideas that specifically focus on scientific and clinical prostate cancer issues, which, if successfully addressed, have the potential to make a major impact in eliminating death from prostate cancer and enhancing the well-being of men experiencing the impact of the disease.

Website

Deadline: 5pm ET July 7, 2017 (Pre-Application); September 28, 2017 (Application)


DoD Duchenne Muscular Dystrophy, Investigator-Initiated Research Award
Department of Defense

Description: The DMDRP Investigator-Initiated Research Award (IIRA) supports translational research that will accelerate the movement of promising ideas in Duchenne research into clinical applications. Translational research may be defined as an integration of basic science and clinical observations with the specific goal of developing new therapies. The ultimate goal of translational research is to move a concept or observation forward into clinical application. However, Principal Investigators (PIs) should not view translational research as a one-way continuum from bench to bedside. The research plan should involve a reciprocal flow of ideas and information between basic and clinical science. Within this continuum, the IIRA supports later-stage translational research projects, including early-phase, proof-of-principle clinical trials and correlative studies to better inform development of drugs, devices, and other interventions. Research projects may also include preclinical studies utilizing animal models, human subjects, or human anatomical substances.

Website

Deadline: 5pm ET July 19, 2017 (Pre-Application); October 18, 2017 (Application)


DoD Peer Reviewed Medical Focused Program Award

Description: The PRMRP Focused Program Award mechanism is intended to optimize research and accelerate the solution for a critical question related to at least one of the Congressionally directed FY17 PRMRP Topic Areas through a synergistic, multidisciplinary research program. The anticipated total costs budgeted for the entire period of performance for an FY17 PRMRP Focused Program Award will not exceed $10M.

Website

Deadline: 5pm ET July 20, 2017 (Pre-Application); October 26, 2017 (Application)


DoD Peer Reviewed Medical Investigator-Initiated Research Award

Description: The PRMRP Investigator-Initiated Research Award is intended to support studies that will make an important contribution toward research and/or patient care for a disease or condition related to at least one of the Congressionally directed FY17 PRMRP Topic Areas. The rationale for a research idea may be derived from a laboratory discovery, population-based studies, a clinician’s first-hand knowledge of patients, or anecdotal data. Applications must include relevant data that support the rationale for the proposed study. These data may be unpublished or from the published literature.

Website

Deadline: 5pm ET July 13, 2017 (Pre-Application); October 18, 2017 (Application)


DoD Peer Reviewed Medical Technology/Therapeutic Development Award

Description: The PRMRP Technology/Therapeutic Development Award is a product-driven award mechanism intended to provide support for the translation of promising preclinical findings into products for clinical applications, including prevention, detection, diagnosis, treatment, or quality of life, in at least one of the Congressionally directed FY17 PRMRP Topic Areas. Products in development should be responsive to the healthcare needs of military Service members, Veterans, and/or beneficiaries.

Website

Deadline: 5pm ET July 13, 2017 (Pre-Application); October 18, 2017 (Application)


DoD Peer Reviewed Medical Clinical Trial Award

Description: The PRMRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on a disease or condition addressed in at least one of the Congressionally directed FY17 PRMRP Topic Areas. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first in human, Phase 0) to demonstrate feasibility or inform the design of more advanced trials, through large-scale trials to determine efficacy in relevant patient populations. All studies must be responsive to the healthcare needs of the military Service members, Veterans, and/or beneficiaries; however, the use of military or Veteran populations is not required.

Website

Deadline: 5pm ET, July 20, 2017 (Pre-Application); October 26, 2017


DoD Peer Reviewed Medical Discovery Award

Description: The intent of the PRMRP Discovery Award is to support innovative, non-incremental, high-risk/potentially high-reward research that will provide new insights, paradigms, technologies, or applications. Studies supported by this award are expected to lay the groundwork for future avenues of scientific investigation. The proposed research project should include a well-formulated, testable hypothesis based on a sound scientific rationale and study design.

Website

Deadline: 5pm ET July 19, 2017 (Pre-Application); August 2, 2017 (Application)


Peer Reviewed Orthopaedic Applied Research Award

Description: The FY17 PRORP Applied Research Award (ARA) seeks applied research applications focused on advancing optimal treatment and restoration of function for military personnel with musculoskeletal injuries sustained during combat or combat-related activities. It is expected that any research findings would also provide benefit to the general population. To meet the intent of the award mechanism, applications must specifically address a primary FY17 PRORP Focus Area listed in Section II.A.1, above. Awards may not be used to support fundamental basic research. Basic research is defined as research directed toward greater knowledge or understanding of the fundamental aspects of phenomena and of observable facts without specific applications toward process or products in mind. The FY17 PRORP ARA is focused on applied research, defined as work that refines concepts and ideas into potential solutions with a view toward evaluating technical feasibility of promising new knowledge products, pharmacologic agents, behavioral and rehabilitation interventions, diagnostic and therapeutic techniques, clinical guidance, and/or emerging approaches and technologies. The anticipated total costs budgeted for the entire period of performance for an FY17 PRORP ARA award will not exceed $750,000.

Website

Deadline: 5pm ET July 12, 2017 (Pre-Application); September 27, 2017 (Application)


Peer Reviewed Orthopaedic Clinical Translational Research Award

Description: The FY17 PRORP Clinical Translational Research Award is intended to support high-impact and/or new/emerging clinical research that may or may not be ready for a full-scale randomized controlled clinical trial. Projects should include translational research that evaluates the effectiveness of healthcare practices and/or interventions in neuromusculoskeletal injuries rehabilitation. Projects should demonstrate potential to impact the standard of care, as well as contribute to evidence-based guidelines for the evaluation and care of military or Veteran patients with orthopaedic injuries including, but not limited to, amputation and/or limb salvage. One goal is to better understand and optimize the experiences, health, functional abilities, and quality of life of individuals who receive treatment for traumatic orthopaedic injuries. Another goal is to identify the most effective diagnosis, treatment, rehabilitation, and prevention options available to support critical decision making for patients, clinicians, other caregivers, and policymakers. Proposed projects should be designed to provide information about the impact, advantages, disadvantages, and risks of specific healthcare practices and interventions.

Website

Deadline: 5pm ET July 12, 2017 (Pre-Application); September 27, 2017


Peer Reviewed Orthopaedic Integrated Clinical Trial Award

Description: The PRORP Integrated Clinical Trial Award (ICTA) supports the rapid implementation of an interdisciplinary clinical trial that integrates both surgical and rehabilitation strategies and has the potential to have a major impact on the treatment of combat-related orthopaedic injuries and/or the treatment of non-battle injuries that significantly impact unit readiness and return-to-duty/- work rates. Projects that follow patients across the continuum of care are highly encouraged. The projects should include both surgical and rehabilitation strategies that create a cohesive project. Surgical strategies are reconstruction and repair and/or application of biologics, pharmaceuticals, and devices for the purpose of restoration of native architecture, composition, and function of traumatically injured tissues. Rehabilitative strategies are those that restore function following injury or illness, with the goal of optimal health and independence. Projects should integrate principles and approaches from surgical and rehabilitative strategies, beyond what each approach would result in alone, with the goal of optimizing form, function, and independence for those who have sustained traumatic orthopaedic injuries. Care should be taken to avoid or account for confounding factors in the analyses.

Website

Deadline: 5pm ET July 12, 2017 (Pre-Application); September 27, 2017 (Application)


Peer Reviewed Orthopaedic Clinical Trial Award

Description: The PRORP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a major impact on military combat-related orthopaedic injuries or non-battle injuries that significantly impact unit readiness and return to duty/work rates. Funding from this award mechanism must support a clinical trial and may not be used for preclinical research studies. A clinical trial is defined as a prospective accrual of human subjects where an intervention (e.g., device, drug, biologic, surgical procedure, rehabilitative modality, behavioral intervention, or other) is tested on a human subject for a measurable outcome with respect to safety, effectiveness, and/or efficacy. This outcome represents a direct effect on the human subject of that intervention or interaction. Principal Investigators (PIs) seeking funding for a preclinical research project should consider one of the other award mechanisms/funding opportunities being offered.

Website

Deadline: 5pm ET July 12, 2017 (Pre-Application); September 27, 2017 (Application)


DoD Prostate Cancer Clinical Consortium Award

Description: The PCRP Clinical Consortium Award mechanism was first offered in FY05, and again in FY06, FY08, and FY13. In FY16, the Clinical Consortium Research Site Award was offered. A total of 75 Clinical Consortium Award applications have been received, and 42 have been recommended for funding.The anticipated direct costs budgeted for the entire period of performance for an FY17 PCRP Clinical Consortium Award will not exceed $3,600,000 for the Coordinating Center and will not exceed $600,000 for each Clinical Research Site.

Website

Deadline: 5PM ET August 24, 2017 (Pre-Application); September 7, 2017 (Application)


DoD Spinal Cord Injury Research Program, Translational Research Award

Description: Applications should articulate both the short- and long-term impact of the proposed research. Projects should address one or more of the FY17 SCIRP Areas of Encouragement or other research areas relevant to the mission of the SCIRP.The ultimate goal of translational research is to move an observation forward into clinical application and accelerate the clinical introduction of healthcare products, technologies, or practice guidelines. Observations that drive a research idea may be derived from a laboratory discovery, population-based studies, or a clinician’s first-hand knowledge of patients and anecdotal data. However, Principal Investigators (PIs) should not view translational research as a one-way continuum from bench to bedside. The research plan should involve a reciprocal flow of ideas and information between basic and clinical science. Developmental pathways for translational research that may be useful for designing translational research studies for support under this mechanism may be found at http://clincancerres.aacrjournals.org/content/ 14/18/5664.full (a report of the National Cancer Institute Translational Research Working Group); applicants are strongly encouraged to refer to these pathways in their applications.

Website

Deadline: 5pm ET August 8, 2017 (Pre-Application); November 29, 2017


DoD Spinal Cord Injury Research Program, Clinical Research Development Award

Description: The FY17 SCIRP CRDA is intended to support planning and development activities necessary to initiate a future clinical study with the potential to have a significant impact on SCIs. The future study to be developed through the CRDA may be clinical research or a clinical trial (as defined in the full announcement). The FY17 SCIRP CRDA also encourages the inclusion of junior investigators on the research team. Relevance of the research to military and/or Veteran populations affected by SCI is a key element of this award mechanism. Collaboration with military or VA researchers and clinicians is highly encouraged. Inclusion of active duty military or Veteran populations is very highly encouraged. If the research will involve other populations, the relevance to the military or Veteran populations and the rationale for the inclusion of the other populations must be clearly articulated by the applicant. SCIRP CRDA recipients are expected to be ready to apply for advanced funding in the program year following completion of their CRDA and are encouraged to apply for future SCIRP funding through an appropriate FY19 or FY20 SCIRP Program Announcement, if offered. Release of FY19 or FY20 SCIRP Program Announcements and any subsequent awards will be contingent upon the availability of Federal funds for the program and competitive selection. Award of an FY17 SCIRP CRDA is in no way an assurance of funding for a future SCIRP award(s).

Website

Deadline: 5pm ET August 8, 2017 (Pre-Application); November 29, 2017 (Application)


DoDO Spinal Cord Injury Research Program, Qualitative Research Award

Description: The intent of the Qualitative Research Award is to support qualitative research studies that will help researchers and clinicians better understand the experiences of individuals with SCI and thereby identify the most effective path(s) for adjusting to disability and/or improving overall quality of life, health, and functional status after SCI. This mechanism is specifically focused on military and Veteran populations in the years after SCI, examining the issues, barriers, and promoters of success for Service members during the transition from initial injury and acute care through rehabilitation and community reintegration; therefore, collaboration with military and VA researchers and clinicians is encouraged. Factors that may affect the rehabilitation and reintegration of spinal cord-injured Service members include, but are not limited to, age, gender, ethnicity, family members/caregivers, psychological health, severity of injury, type of medical care (e.g., civilian, VA, or military facility), and co-morbid conditions. A key feature of the QRA is the inclusion of military and/or Veteran populations in the years after SCI. Applicants should clearly describe how their study design, including recruitment strategies and access to appropriate populations, as applicable, will enable them to meet this intent.

Website

Deadline: 5pm ET August 8, 2017 (Pre-Application); November 29, 2017 (Application)


DoD Neurofibromatosis Research Program, Exploration-Hypothesis Development Award

Description: The NFRP Exploration – Hypothesis Development Award supports the initial exploration of innovative, high-risk, high-gain, and potentially groundbreaking concepts in NF research. Studies supported by this award mechanism are expected to lay the groundwork for future avenues of scientific investigation. The proposed research project should include a well-formulated, testable hypothesis based on strong scientific rationale and study design. The presentation of preliminary and/or published data is encouraged, but not required. The proposed research project should be innovative. Innovative research may introduce a novel paradigm, challenge existing paradigms, examine existing problems from novel perspectives, or exhibit other highly creative qualities. Research that is an incremental advance upon published data is not considered innovative and is not consistent with the intent of this award mechanism. It is the responsibility of the Principal Investigator (PI) to clearly and explicitly articulate how the proposed research project is innovative in the field of NF.

Website

Deadline: 5pm ET July 26, 2017 (Pre-Application); August 9, 2017 (Application)


DoD Neurofibromatosis Research Program, Investigator-Initiated Research Award

Description: The NFRP Investigator-Initiated Research Award supports highly rigorous, high-impact research projects that have the potential to make an important contribution to NF research and/or patient care. Research projects may focus on any phase of research, excluding clinical trials. The rationale for a research idea may be derived from laboratory discovery, population-based studies, a clinician’s firsthand knowledge of patients, or anecdotal data. Applications must include preliminary and/or published data that are relevant to NF and the proposed research project.

Website

Deadline: 5pm ET July 26, 2017 (Pre-Application); August 9, 2017 (Application)


DoD Neurofibromatosis Research Program, New Investigator Award

Description: The intent of the NFRP New Investigator Award is to support the continued development of promising independent investigators and/or the transition of established investigators from other research fields into a career in the field of NF research. Prior experience in NF research is not required. However, Principal Investigators (PIs) with a limited background in NF research are strongly encouraged to have a collaborator who is experienced in the NF field.

Website

Deadline: 5pm ET July 26, 2017 (Pre-Application); August 9, 2017 (Application)


DoD Neurofibromatosis Research Program, Clinical Trial Award

Description: The NFRP Clinical Trial Award supports research with the potential to have a major impact on the treatment or management of NF. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept (i.e., pilot, first-in-human, or Phase 0) trials to demonstrate feasibility or inform the design of more advanced trials, through large-scale trials to determine efficacy in relevant patient populations.

Website

Deadline: 5pm ET July 26, 2017 (Pre-Application); August 9, 2017 (Application)


DoD Autism Research Program, Clinical Translational Research Award

Description: The Clinical Translational Research Award is intended to support early-phase, proof-of-principle translational studies that will examine hypothesis-based, innovative interventions that have the potential to address current clinical deficits for ASD. Applicants are strongly encouraged to address one of the ARP Areas of Interest. If the proposed project does not address any of the FY17 ARP Clinical Translational Research Award Areas of Interest, the application should describe how the project will nevertheless address a critical need of the ASD community. Outcomes from studies funded by this award are anticipated to provide scientific rationale for subsequent development of larger, efficacy-based clinical trials of interventions that will transform ASD clinical care.

Website

Deadline: 5pm ET July 26, 2017 (Pre-Application); October 19, 2017 (Application)


DoD Autism Research Program, Idea Development Award

Description: The ARP Idea Development Award supports the development of innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with ASD. This award mechanism is designed to support innovative ideas with the potential to yield impactful data and new avenues of investigation.

Website

Deadline: 5pm July 26, 2017 (Pre-Application); October 19, 2017 (Application)


DoD Autism Research Program, Clinical Trial Award

Description: The ARP Clinical Trial Award supports research with the potential to have a major impact on the treatment or management of ASD. Funding from this award mechanism must support a clinical trial and may not be used for preclinical research studies. A clinical trial is defined as a prospective accrual of human subjects where an intervention (e.g., device, drug, biologic, surgical procedure, rehabilitative modality, behavioral intervention, or other) is tested on a human subject for a measurable outcome with respect to safety, effectiveness, and/or efficacy. This outcome represents a direct effect on the human subject of that intervention or interaction. Principal Investigators (PIs) seeking funding for a preclinical research project should consider the FY17 ARP Idea Development Award (Funding Opportunity Number: W81XWH-17-ARP-IDA). Further, PIs seeking funding for the initial development and proof-of-principle testing of an intervention, and not a robust statistically powered clinical trial, should consider the FY17 ARP Clinical Translational Research Award (Funding Opportunity Number: W81XWH-17-ARP-CTRA). The term “human subjects” is used in this Program Announcement to refer to individuals who will be recruited for or who will participate in the proposed clinical trial. For more information, a Human Subject Resource Document is provided at https://ebrap.org/eBRAP/public/Program.htm.

Website

Deadline: 5pm ET July 26, 2017 (Pre-Application); October 19, 2017 (Application)


DoD Military Burn Clinical Trial Award

Description: The MBRP Clinical Trial Award mechanism is being offered for the first time in FY17. The objective of this Program Announcement is to explore innovative approaches to accelerate the translation of knowledge advances into new treatments for the Service members who sustain burn injuries. The results of the research funded through the FY17/18 MBRP Clinical Trial Award are expected to increase the body of knowledge and materiel products available to professionals and practitioners in health, medical science, and related fields. The research impact is expected to benefit both civilian and military communities. The FY17/18 MBRP Clinical Trial Award supports clinical research studies with the potential to have a major impact on the prevention, treatment, and mitigation of debilitating burn scars that are relevant to military personnel. The specific intent is to improve functional outcomes and/or assess clinical efficacy and safety of different treatment modalities (e.g., dressing topics, biologics, cell-based therapies, mechanical, photonics).

Website

Deadline: 5pm ET August 3, 2017 (Pre-Application); October 19, 2017 (Application)


DoD Parkinson’s Research Program, Early Investigator Research Award

Description: The PRP Early Investigator Research Award supports Parkinson’s disease-focused research opportunities for individuals in the early stages of their careers, under the guidance of a designated Mentor. The Early Investigator is considered the Principal Investigator (PI) of the application and must exhibit strong potential for, and commitment to, pursuing a career as an investigator at the forefront of Parkinson’s disease research; however, the PI is not required to have previous Parkinson’s disease research experience. Clinical fellows applying to the PRP EIRA mechanism should be specializing in movement disorders. Applications must include at least one Mentor, appropriate to the proposed research project, who has experience in Parkinson’s disease research and mentoring as demonstrated by a record of active funding, recent publications, and successful mentorship. The selected Mentor(s) should also demonstrate a clear commitment to the development of the PI toward independence as a Parkinson’s disease researcher.

Website

Deadline: 5pm ET August 17, 2017 (Pre-Application); August 31, 2017 (Application)


DoD Parkinson’s Research Program, Investigator- Initiated Research Award

Description: The PRP Investigator-Initiated Research Award supports highly rigorous, high-impact research projects that have the potential to make an important contribution to Parkinson’s disease research and/or patient care. This award mechanism supports the full spectrum of research from basic science through clinical research that specifically focuses on scientific and clinical Parkinson’s disease issues, which, if successfully addressed, have the potential to make a major impact in understanding, preventing, diagnosing, or treating Parkinson’s disease or enhancing the well-being of individuals experiencing the impact of the disease.

Website

Deadline: 5pm ET August 17, 2017 (Pre-Application); August 31, 2017 (Application)


DoD Peer Reviewed Cancer, Career Development Award

Description: The FY17 PRCRP Career Development Award supports independent, early-career investigators to conduct impactful research with the mentorship of an experienced cancer researcher (i.e., the Designated Mentor) as an opportunity to obtain the funding, guidance, and experience necessary for productive, independent careers at the forefront of cancer research. This award supports impactful research projects with an emphasis on discovery. Under this award mechanism, the early-career investigator is considered the Principal Investigator (PI), and the application should focus on the PI’s research and career development. It should be clear that the proposed research is intellectually designed by the PI and not a product of the Designated Mentor. Preliminary data are not required.

Website

Deadline: 5pm ET September 12, 2017 (Pre-Application); September 28, 2017 (Application)


Drummond Foundation

Aging-related Research

Description:  This funding opportunity is aimed at clinical investigators who are interested in aging-related research and improving the quality of life of socially, mentally, or physically disadvantaged older adults and their families.


Deadline: May 15, 2017 (LOI), August 31, 2017 (Application)



Government of Canada - Gouvernement du Canada

Vanier Canada Graduate Scholarships

Description: The Government of Canada launched the Vanier Canada Graduate Scholarships (Vanier CGS) program in 2008 to strengthen Canada's ability to attract and retain world-class doctoral students and establish Canada as a global centre of excellence in research and higher learning. Vanier Scholars demonstrate leadership skills and a high standard of scholarly achievement in graduate studies in the social sciences and/or humanities, natural sciences and/or engineering and health.

Candidates must be nominated by the institution at which they want to study. Candidates cannot apply directly to the Vanier Canada Graduate Scholarships (Vanier CGS) program.

Applications are initiated in one of two ways. Either:

  • the student informs the faculty of graduate studies at the selected institution of their intent to apply to the Vanier CGS program; or
  • the institution initiates the nomination process by contacting the desired candidate.


Website

Deadline: Institutional deadline: please consult your department.



Grand Challenges Canada - Grands Défis Canada

Stars in Reproductive, Maternal, Newborn and Child Health

Description: Through the Stars in Reproductive, Maternal, Newborn and Child Health Request for Proposals, Grand Challenges Canada seeks bold ideas for products, services and implementation models that could transform how persistent challenges in reproductive, maternal, newborn and child health are addressed in low- and middle-income countries. Of particular interest to Grand Challenges Canada are innovations to improve reproductive, maternal, newborn and child health in humanitarian contexts, notably among internally displaced and refugee populations, as well as innovations that improve the sexual and reproductive health and rights of women and girls, so that they are empowered and have greater influence over their lives and futures. Successful proposals will be awarded seed grants of up to CAD $100,000 for up to 12– 18 months to develop and test the proposed innovation.

Website

Deadline: 3pm ET August 3, 2017 (Application)



Human Toxicology Project Consortium

Roadmaps to Human Biology-based Disease Research

Description: To support strategic scientific dialogue around the concept of extending the vision of “21st century toxicology” to the wider biosciences, Humane Society International and The Humane Society of the United States are offering grants of up to $10,000 (USD) in funding to support the development and open-access publication of in-depth, independent review articles in discrete areas of human disease/biomedicine by health scientists with relevant expertise.

Website

Deadline: June 30, 2017 (Application)


Kids Brain Health Network

Training Fellowship

Description: The awards will be made to outstanding predoctoral and postdoctoral fellows undertaking a program of research training that incorporates original research into the origins, early detection and effective treatment of disorders of brain development. Fellows with programs of study with a concentration on knowledge translation and in neuroethical issues in the developmental neurosciences and neurodisabilities are also encouraged. These programs of study will further our understanding of normal brain development as well as disorders of the developing brain when disrupted by genetic, environmental or acquired injury factors, and ultimately lead to new strategies for prevention and mitigation through early intervention. However, areas of non-developmental origins or neurodegeneration will not be considered for this competition.

Website

Deadline: June 30, 2017 (Institutional Commitment Letter), August 15, 2017 (Application)


Mitacs

Postdoctoral funding: Mitacs Elevate

Description: Mitacs Elevate is a postdoctoral fellowship with a customized research management training component. Fellows address complex challenges through:

  • An exclusive research management curriculum for postdoctoral fellows in any discipline
  • A two-year research project with a partner organization in need of high-level expertise
  • A Partner Organization Business Case, developed to outline project objectives, risks, and stakeholder success criteria, and ensure project value
Elevate fellows progress through the program in a cohort, giving them cross-disciplinary networking and peer-learning opportunities they might not have otherwise in their careers.Over the two-year fellowship, Elevate fellows divide their time between their partner organization project and university-based research with their faculty supervisor.


Website

Deadline: June 7, 2017, 5pm PDT (LOI and Conflict of Interest declaration); June 21, 2017 5pm PDT (Pre-review of Application); July 5, 2017 1pm PDT (Application)



National Institutes of Health - Department of Health and Human Services

Innovation for HIV Vaccine Discovery (R01)

Description: The purpose of this Funding Opportunity Announcement (FOA) is to support high risk, high impact, early discovery research on vaccine approaches to prevent acquisition of or ongoing infection by HIV.


Website

Deadline: July 1, 2017 (Letter of Intent); August 1, 2017 (Application)


Dysregulation of Immune Cell Regulatory Pathways by Mtb in the Context of HIV Infection (R61/R33)

Description: The purpose of this funding opportunity announcement (FOA) is to invite applications to support innovative preclinical research to identify Mycobacterium tuberculosis (Mtb)-mediated changes in key immune cell regulatory pathways in the context of HIV infection and evaluate strategies to reverse these changes to treat TB and TB/HIV infection, limit long-term disease associated tissue damage, and/or potentiate vaccine effectiveness.

Website

Deadline: July 1, 2017 (Letter of Intent); August 1, 2017 (Application)


In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R21)

Description: The purpose of this Funding Opportunity Announcement (FOA) is to: (a) stimulate and accelerate development of novel in vitro and small animal models of HBV/HIV co-infection to accelerate drug discovery/drug development in HBV/HIV co-infection; and (b) stimulate and accelerate a better understanding of the immunopathogenic interactions between HBV and HIV.

Website

Deadline: 5pm June 16, 2017


Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R21)

Description: The purpose of this funding opportunity announcement (FOA) is to invite applications to support innovative research to improve our understanding of innate and adaptive immune dysregulation caused by Type 2 diabetes mellitus (DM) and pre-diabetes that causes increased risk of latent tuberculosis (TB) re-activation and more severe active TB disease with more frequent treatment failure/relapse and death in the context of HIV co-infection.

Website

Deadline: 5pm June 16, 2017


HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research (R21)

Description: The purpose of this Funding Opportunity Announcement (FOA) is to fill scientific gaps needed to (a) inform HBV functional cure strategies by furthering our understanding of unique challenges impacting HBV and HIV co-infected hosts and (b) advance the discovery and development of novel HBV interventions that are safe and achieve a functional cure in HIV and HBV co-infected individuals.

Website

Deadline: 5pm June 16, 2017 (Application)


In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R21)

Description: The purpose of this Funding Opportunity Announcement (FOA) is to: (a) stimulate and accelerate development of novel in vitro and small animal models of HBV/HIV co-infection to accelerate drug discovery/drug development in HBV/HIV co-infection; and (b) stimulate and accelerate a better understanding of the immunopathogenic interactions between HBV and HIV.

Website

Deadline: 5pm June 16, 2017 (Application)


Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R21)

Description: The purpose of this funding opportunity announcement (FOA) is to invite applications to support innovative research to improve our understanding of innate and adaptive immune dysregulation caused by Type 2 diabetes mellitus (DM) and pre-diabetes that causes increased risk of latent tuberculosis (TB) re-activation and more severe active TB disease with more frequent treatment failure/relapse and death in the context of HIV co-infection.

Website

Deadline: 5pm June 16, 2017 (Application)


HIV Drug Resistance: Genotype-Phenotype-Outcome Correlations (R21)

HIV Drug Resistance: Genotype-Phenotype-Outcome Correlations (R21)

Description: The purpose of this Funding Opportunity is to support studies that will evaluate HIV drug resistance and its relationship to treatment success. Applications are sought proposing studies of genotype/phenotype correlations in diverse subtypes, the relationship between minority variants and treatment outcomes and on the reasons for the discordance between genotype and treatment success or failure. Laboratory evaluations of samples with clinical correlates in patients on recommended regimens are encouraged.

Website

Deadline: 5pm June 16, 2017 (Application)


Silencing of HIV-1 Proviruses (R61/R33)

Description: This Funding Opportunity Announcement (FOA) encourages exploratory and developmental bi-phasic research applications to support the identification and optimization of small molecules or RNAs that interact with host epigenetic machinery to mediate long-term or permanent epigenetic silencing of HIV-1 proviruses.

Website

Deadline: 5pm December 6, 2017 (Application)


Partnerships for the Development of Vaccines and Immunoprophylactics Targeting Multiple Antimicrobial-Resistant Bacteria (R01)

Description: The purpose of this Funding Opportunity Announcement (FOA) is to support milestone-driven projects focused on discovery, establishment of proof-of-concept for, and/or preclinical development of, lead candidate vaccines or immunoprophylactics that target multiple antimicrobial-resistant Gram-negative bacterial pathogens prevalent in nosocomial infections: carbapenem-resistant Enterobacteriaceae (CRE), multidrug-resistant (MDR) Acinetobacter and MDR Pseudomonas aeruginosa.

Website

Deadline: September 4, 2017 (Letter of Intent); 5pm MT October 4, 2017 (Application)


Partnerships  for Development of Clinically Useful Diagnostics for Antimicrobial-Resistant Bacteria (R01)

Description: The objective of this initiative is to support milestone-driven projects focused on the development of clinically informative diagnostic platforms that identify select antimicrobial-resistant bacterial pathogens and determine associated antimicrobial sensitivity and/or resistance. Applications must include a Product Development Strategy and demonstrate substantive investment by at least one industrial participant.

Website

Deadline: September 4, 2017


Imaging the Persistent HIV Reservoir (R01)

Description: The purpose of this Funding Opportunity Announcement (FOA) is to support the development of imaging approaches to identify and characterize persistent HIV reservoirs in patients undergoing suppressive antiretroviral therapy (ART) and to quantify the nature and size of these reservoirs in response to therapeutic interventions.

Website

Deadline: October 5, 2017 (Application)


Optimizing HIV Phylodynamics to Target and Interrogate Clusters (OPTICs) (R21)

Description: The purpose of this Funding Opportunity Announcement (FOA) is to support exploratory basic research to develop innovative phylodynamic approaches to identify and prioritize the most rapidly growing HIV transmission clusters within a given population of individuals in near-real time.

Website

Deadline: October 16, 2017


Administrative Supplements for Research on Dietary Supplements (Admin Supp)

Description: This Funding Opportunity Announcement (FOA) announces the availability of administrative supplements to support research in which the supplemental funding would investigate the role of dietary supplements and/or their ingredients in health maintenance and disease prevention. Parent awards need not be focused on dietary supplements; this FOA may provide support to include dietary supplements within the scope of relevant research projects. Research interests of ODS are not limited to specific health conditions, organ systems or population groups. ODS supports all types of research, including pre-clinical, clinical, behavioral, and epidemiological. Additionally, ODS supports research and training programs that build future research capacity for studying the role of dietary supplements in health and disease prevention. Primary consideration for support will be given to applications that stimulate dietary supplement research where it is lacking or lagging, clarify gaps, opportunities and balance between benefits and risks where data are in conflict, target special population groups where additional science on dietary supplements is needed, and focus on the use of dietary supplements in improving or maintaining health and reducing the risk of chronic disease.  This FOA will not support new clinical trials.

Website

Deadline: 5pm MT October 15, 2017


Imaging the Persistent HIV Reservoir (R01)

Description: The purpose of this Funding Opportunity Announcement (FOA) is to support the development of imaging approaches to identify and characterize persistent HIV reservoirs in patients undergoing suppressive antiretroviral therapy (ART) and to quantify the nature and size of these reservoirs in response to therapeutic interventions.

Website

Deadline: October 5, 2017 (Application)


Partnerships  for Development of Clinically Useful Diagnostics for Antimicrobial-Resistant Bacteria (R01)

Description: The objective of this initiative is to support milestone-driven projects focused on the development of clinically informative diagnostic platforms that identify select antimicrobial-resistant bacterial pathogens and determine associated antimicrobial sensitivity and/or resistance. Applications must include a Product Development Strategy and demonstrate substantive investment by at least one industrial participant.

Website

Deadline: 5pm MT October 4, 2017 (Application)


Partnerships for the Development of Vaccines and Immunoprophylactics Targeting Multiple Antimicrobial-Resistant Bacteria (R01)

Description: The purpose of this Funding Opportunity Announcement (FOA) is to support milestone-driven projects focused on discovery, establishment of proof-of-concept for, and/or preclinical development of, lead candidate vaccines or immunoprophylactics that target multiple antimicrobial-resistant Gram-negative bacterial pathogens prevalent in nosocomial infections: carbapenem-resistant Enterobacteriaceae (CRE), multidrug-resistant (MDR) Acinetobacter and MDR Pseudomonas aeruginosa.

Website

Deadline: 5pm MT October 4, 2017 (Application)


Silencing of HIV-1 Proviruses (R61/R33)

Description: This Funding Opportunity Announcement (FOA) encourages exploratory and developmental bi-phasic research applications to support the identification and optimization of small molecules or RNAs that interact with host epigenetic machinery to mediate long-term or permanent epigenetic silencing of HIV-1 proviruses

Website

Deadline: November 6, 2017 (Letter of Intent); 5pm MT December 6, 2017 (Application)


HIV Drug Resistance: Genotype-Phenotype-Outcome Correlations (R21)

Description: The purpose of this Funding Opportunity is to support studies that will evaluate HIV drug resistance and its relationship to treatment success. Applications are sought proposing studies of genotype/phenotype correlations in diverse subtypes, the relationship between minority variants and treatment outcomes and on the reasons for the discordance between genotype and treatment success or failure. Laboratory evaluations of samples with clinical correlates in patients on recommended regimens are encouraged.

Website

Deadline: Octover 16, 2017 (Application)


HIV Drug Resistance: Genotype-Phenotype-Outcome Correlations (R01)

Description: The purpose of this Funding Opportunity Announcement is to support studies that will evaluate HIV drug resistance and its relationship to treatment success. Applications are sought proposing studies of genotype/phenotype correlations in diverse subtypes, the relationship between minority variants and treatment outcomes and on the reasons for the discordance between genotype and treatment success or failure. Laboratory evaluations of samples with clinical correlates in patients on recommended regimens are encouraged.

Website

Deadline: October 5, 2017 (Application)


The Royal's Institute of Mental Health Research

The Royal-Mach-Gaensslen Prize for Mental Health Research

Description: The Royal-Mach-Gaensslen Prize for Mental Health Research was established in 2015, and is awarded annually to recognize and support rising star Canadian research scientists with a focus in the area of mental health. This annual national Prize provides funding to outstanding rising star researchers who are affiliated with a Canadian academic or clinical research institution in the field of mental health, to encourage them to continue to pursue their research interests in Canada. It recognizes those with a demonstrated track record in research with excellence in scientific rigor, innovative thinking, imagination and originality and a clear ability to work in partnership with other disciplines and/or research teams external to the institution with which they are affiliated.

Website

Deadline: July 15, 2017


Weston Brain Institute

Canada: Rapid Response

Description: Seed funding (up to $200,000 per project for up to 18 months) to provide support for high-risk, high-reward projects that will impact neurodegenerative diseases of aging.

Website

Deadline: May 9, 2017 (Application - PD related diseases); July 5, 2017 (Application - AD related diseases)


Postdoctoral Scholars

Description: To encourage development of the next generation of leading Canadian neuroscientists by providing postdoctoral scholars with international training to accelerate their careers in translational research for neurodegenerative disease(s) of aging. Scholars should plan to build their careers in Canada upon completion of their postdoctoral position. Maximum funding available is £57,000 per year (£44,000 per year + benefits) for 2 years.

Website

Deadline: July 26, 2017 (Application)


Natural Sciences and Engineering


Canada Council for the Arts

Killam Program

Description: The Killam Program at the Canada Council also includes the Killam Research Fellowships, which support scholars engaged in research projects of outstanding merit in the humanities, social sciences, natural sciences, health sciences, engineering and interdisciplinary studies within these fields.

Website

Contact: Luiza Pereira at luiza.pereira@canadacouncil.ca

Deadline: May 15, 2017 (Application); June 15, 2017 (Nomination)


Deadline: May 15, 2017 (Application); June 15, 2017 (Nomination)


Government of Canada - Department of Fisheries and Oceans

Coastal Restoration Fund

Description: The CRF is a $75 million contribution program established under the Ocean Protection Plan to support coordinated and strategic coastal aquatic habitat restoration projects that contribute to the mitigation of stressors affecting marine life and their habitats. The CRF will provide $15M/year for the next 5 years to Indigenous groups, community-based organizations, conservation groups, and academic researchers/institutions to undertake projects along Canada’s coasts that:

  • Contribute to strategic planning and studies in key coastal areas;
  • Rehabilitate aquatic habitats that contribute to the mitigation of stressors affecting marine life and their habitats;
  • Contribute to the long-term sustainability of aquatic coastal habitats through monitoring and maintenance; and
  • Encourage and build local community capacity to maintain and restore aquatic habitats.


Website

Deadline: July 12, 2017



Mitacs

Globalink Research Award - Special Opportunity

Description: The Mitacs Globalink Research Award supports international research collaboration. Special research funding is available for graduate students with uncertain status in their current location, to conduct research at a Canadian university.

Website

Deadline: Ongoing


Postdoctoral funding: Mitacs Elevate

Description: Mitacs Elevate is a postdoctoral fellowship with a customized research management training component. Fellows address complex challenges through:

  • An exclusive research management curriculum for postdoctoral fellows in any discipline
  • A two-year research project with a partner organization in need of high-level expertise
  • A Partner Organization Business Case, developed to outline project objectives, risks, and stakeholder success criteria, and ensure project value
Elevate fellows progress through the program in a cohort, giving them cross-disciplinary networking and peer-learning opportunities they might not have otherwise in their careers.Over the two-year fellowship, Elevate fellows divide their time between their partner organization project and university-based research with their faculty supervisor.

Website

Deadline: June 7, 2017, 5pm PDT (LOI and Conflict of Interest declaration); June 21, 2017 5pm PDT (Pre-review of Application); July 5, 2017 1pm PDT (Application)


Globalink Research Internship

Description:  From May to September, top-ranked international undergraduates participate in a 12 week research internship under the supervision of Canadian university faculty members in a variety of academic disciplines, from science, engineering and mathematics to the humanities and social sciences.

Website

Deadline: June 14, 2017 (Application for faculty)


Natural Sciences and Engineering Research Council of Canada (NSERC)

Please refer to our NSERC page for funding related news, including information on upcoming deadlines.


Government of Canada - Gouvernement du Canada

Vanier Canada Graduate Scholarships

Description: The Government of Canada launched the Vanier Canada Graduate Scholarships (Vanier CGS) program in 2008 to strengthen Canada's ability to attract and retain world-class doctoral students and establish Canada as a global centre of excellence in research and higher learning. Vanier Scholars demonstrate leadership skills and a high standard of scholarly achievement in graduate studies in the social sciences and/or humanities, natural sciences and/or engineering and health.

Candidates must be nominated by the institution at which they want to study. Candidates cannot apply directly to the Vanier Canada Graduate Scholarships (Vanier CGS) program.

Applications are initiated in one of two ways. Either:

  • the student informs the faculty of graduate studies at the selected institution of their intent to apply to the Vanier CGS program; or
  • the institution initiates the nomination process by contacting the desired candidate.

Website

Deadline: Institutional deadline: please consult your department.



Tecterra

Industry Investment Program

Description: Enables and supports small to medium size Alberta companies in the development and commercialization of innovative geospatial solutions for integrated resource management. Funding will focus on solutions for energy, forestry, agriculture, environment, land management and land development.

Website

Contact: Richard Gorecki at rgorecki@tecterra.com

Deadline: Ongoing


Social Sciences and the Humanities


Canada Council for the Arts

Killam Program

Description: The Killam Program at the Canada Council also includes the Killam Research Fellowships, which support scholars engaged in research projects of outstanding merit in the humanities, social sciences, natural sciences, health sciences, engineering and interdisciplinary studies within these fields.

Website

Contact: Luiza Pereira at luiza.pereira@canadacouncil.ca

Deadline: May 15, 2017 (Application); June 15, 2017 (Nomination)


Government of Canada - Gouvernement du Canada

Vanier Canada Graduate Scholarships

Description: The Government of Canada launched the Vanier Canada Graduate Scholarships (Vanier CGS) program in 2008 to strengthen Canada's ability to attract and retain world-class doctoral students and establish Canada as a global centre of excellence in research and higher learning. Vanier Scholars demonstrate leadership skills and a high standard of scholarly achievement in graduate studies in the social sciences and/or humanities, natural sciences and/or engineering and health.

Candidates must be nominated by the institution at which they want to study. Candidates cannot apply directly to the Vanier Canada Graduate Scholarships (Vanier CGS) program.

Applications are initiated in one of two ways. Either:

  • the student informs the faculty of graduate studies at the selected institution of their intent to apply to the Vanier CGS program; or
  • the institution initiates the nomination process by contacting the desired candidate.

Website

Deadline: Institutional deadline: please consult your department.



Government of Canada - Employment and Social Development Canada

New Horizons for Seniors Program – Community-Based Projects

Description: Organizations that want to help seniors make a difference in the lives of others and in their communities are eligible to receive federal grants and contributions funding. Projects must be led or inspired by seniors and address one or more of the following five program objectives:
  • promoting volunteerism among seniors and other generations;
  • engaging seniors in the community through the mentoring of others;
  • expanding awareness of elder abuse, including financial abuse;
  • supporting the social participation and inclusion of seniors; and
  • providing capital assistance for new and existing community projects and/or programs for seniors.
Organizations can apply for funding for community-based and pan-Canadian projects in the same year.

Website

Deadline: 11:59 PT June 23, 2017 (Application)


Manitoba Gambling Research Program

Conference Grant

Description: Assist researchers to enhance their capabilities within the gambling research field, become up-to-date with recent advances in the gambling field, provide the opportunity to meet and interact with other researchers in the field, and provide the opportunity to present research to peers.

Website

Deadline: Ongoing


Small Grant

Description: Enhance understanding of topics within the Manitoba Gambling Research Program’s research priorities, and increase Manitoba-based gambling research. Support the development of existing and new researchers in the field of responsible gambling and problem gambling research, and build research capacity in Manitoba universities. Support gambling research projects that have practical application, and disseminate information and share expertise on gambling research. The project proposal must demonstrate collaboration with a researcher(s) affiliated with a Manitoba university.

Website

Deadline: July 26, 2017 (Cycle 2 Proposal); October 11, 2017 (Cycle 3 Proposal)


Studentship

Description: Provide financial support to students who undertake gambling research as a part of their undergraduate honours thesis or graduate studies programs in Manitoba. Build research capacity in the province of Manitoba in the gambling field and support the development of quality gambling research in Manitoba.

Website

Deadline: October 18, 2017 (Cycle 2 Application)


The Role of Health Care Providers in Responding to Problem Gambling

Description: The principal investigator must be affiliated with a recognized Canadian university, research company or organization. The principal investigator and co-investigator(s) must demonstrate appropriate level of research training and experience to carry out the proposed research project. The sponsoring organization must be the Canadian university, company or other type of organization of which the principal investigator is affiliated. Please note that collaborating with a Manitoba researcher is not required to be eligible to apply for this Focused Research Project. Researchers from interdisciplinary fields are encouraged to apply.

Website

Deadline: August 23, 2017 (Application)


Mitacs

Postdoctoral funding: Mitacs Elevate

Description: Mitacs Elevate is a postdoctoral fellowship with a customized research management training component. Fellows address complex challenges through:

  • An exclusive research management curriculum for postdoctoral fellows in any discipline
  • A two-year research project with a partner organization in need of high-level expertise
  • A Partner Organization Business Case, developed to outline project objectives, risks, and stakeholder success criteria, and ensure project value
Elevate fellows progress through the program in a cohort, giving them cross-disciplinary networking and peer-learning opportunities they might not have otherwise in their careers.Over the two-year fellowship, Elevate fellows divide their time between their partner organization project and university-based research with their faculty supervisor.

Website

Deadline: June 7, 2017, 5pm PDT (LOI and Conflict of Interest declaration); June 21, 2017 5pm PDT (Pre-review of Application); July 5, 2017 1pm PDT (Application)


Ontario - Ministry of Community and Social Services

Description: The objective of the Developmental Services (DS) Research Grant Fund is to support research capacity and innovative initiatives specifically for the Developmental Services sector.
The Fund has been set aside to support knowledge enhancement across the Developmental Services Sector and to foster knowledge translation and exchange that encourages the use of evidence to inform policy development and decision making.

The DS Research Grant Fund will support research and innovative initiatives that provide evidence or collect data through a variety of means, including: reviews of literature; research and practice syntheses; meta-analyses; qualitative, quantitative and quasi-experimental research studies; case studies and comparisons; and tests of new initiatives through innovative demonstration projects.

The DS Research Grant Fund may not be used to fund parts of research projects that are financially supported through other sources of funding (e.g., SSHRC).

Call for Applications / Demande de candidatures

Application Template / Modèle de demande

Deadline: 5 July, 2017 (Application)

Deadline: May 15, 2017 (LOI), August 31, 2017 (Application)


Human Toxicology Project Consortium


Roadmaps to Human Biology-based Disease Research

Deadline: May 15, 2017 (LOI), August 31, 2017 (Application)


Human Toxicology Project Consortium


Roadmaps to Human Biology-based Disease Rese



PolicyWise for Children & Families

Seed Grant

Description: The Grant funding competition provides funding for research teams to answer policy-relevant research questions in the areas of child, family and community research.

Potential Grant activities include but are not limited to:

  • Small-scale research studies
  • Independent component or phase of a larger study
  • Pilot studies
  • Survey- or questionnaire-based studies
  • Qualitative research
  • Community-based research
  • Secondary data analysis
  • Close out grants
The maximum funding available for a Grant is $40,000. The term of the grant is 12 months.


Website

Deadline: 4pm September 1, 2017 (Application)


Grant

Description: The Grant funding competition provides funding for research teams to answer policy-relevant research questions in the areas of child, family and community research.

Potential Grant activities include but are not limited to:

  • Small-scale research studies
  • Independent component or phase of a larger study
  • Pilot studies
  • Survey- or questionnaire-based studies
  • Qualitative research
  • Community-based research
  • Secondary data analysis
  • Close out grants
The maximum funding available for a Grant is $40,000. The term of the grant is 12 months.


Website

Deadline: 4pm September 1, 2017 (Application)


Doctoral Award

Description: PolicyWise’s full-time Doctoral Award enables academically superior, post-candidacy PhD students to undertake full-time research training with funding provided for a two-year period. The award consists of a stipend and a research allowance. One Doctoral Award is available for this competition.

Doctoral Award applicants must be engaged in a full-time PhD program at an Alberta Institution for the full duration of the award. Applicants must have successfully completed their candidacy examination before the application deadline.

The maximum funding available for a Doctoral Award is $64,000. The term of the grant is 24 months.

Website

Deadline: 4pm September 1, 2017 (Application)


Grand Challenges Canada - Grands Défis Canada

Stars in Reproductive, Maternal, Newborn and Child Health

Description: Through the Stars in Reproductive, Maternal, Newborn and Child


Government of Canada - Gouvernement du Canada

Vanier Canada Graduate Scholarships

Description: The Government of Canada launched the Vanier Canada Graduate Scholarships (Vanier CGS) program in 2008 to strengthen Canada's ability to attract and retain world-class doctoral students and establish Canada as a global centre of excellence in research and higher learning. Vanier Scholars demonstrate leadership skills and a high standard of scholarly achievement in graduate studies in the social sciences and/or humanities, natural sciences and/or engineering and health.

Candidates must be nominated by the institution at which they want to study. Candidates cannot apply directly to the Vanier Canada Graduate Scholarships (Vanier CGS) program.

Applications are initiated in one of two ways. Either:

  • the student informs the faculty of graduate studies at the selected institution of their intent to apply to the Vanier CGS program; or
  • the institution initiates the nomination process by contacting the desired candidate.


Website

Deadline: Institutional deadline: please consult your department.